Applied Clinical Trials
Executives from Atlantic Research Group discuss the importance of CRAs in rare disease clinical trials.
Paul Bishop and Lyle Camblos
Advertisement
Paul Bishop is CEO, Atlantic Research Group (ARG), and can be reached at [email protected] Lyle Camblos is Managing Partner, Atlantic Research Group (ARG) and can be reached at [email protected]
Articles by Paul Bishop and Lyle Camblos
Advertisement
Latest Updated Articles
- The Value of Empowered CRAs in Rare Disease Studies
August 2nd 2017
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
The Data Harmonization Imperative: How AI Is Solving Clinical Research's Biggest Bottleneck
2
ACT Brief: Cross-Asset Site Partnerships, Vaccine Trial Standardization, and Ovarian Cancer Care Gaps
3
SCOPE X: How AI Could Reshape the Sponsor-Site Relationship Over the Next Several Years
4
Patient Engagement Strategies in Anti-Obesity Medication Clinical Trials: Addressing Drop Out Rate and Improving Retention
5